This inventor holds 3 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: Glycomine, Inc.. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2026
Title: Agnes Rafalko: Innovator in Pharmaceutical Carbohydrate Therapies
Introduction
Agnes Rafalko is a notable inventor based in San Francisco, CA, who has made significant contributions to the field of pharmaceutical preparations. With a focus on carbohydrate replacement therapies, her work aims to address various metabolic disorders.
Latest Patents
Agnes Rafalko holds 3 patents related to her innovative research. Her latest patents include methods for the preparation of carbohydrate replacement therapies (CRT) that utilize nanocarriers of carbohydrates and glycolipids. These methods are designed for pharmaceutical delivery to the cell interior, endoplasmic reticulum, and Golgi, specifically targeting the treatment of CDG type I and CDG type II diseases, along with other metabolic disorders.
Career Highlights
Agnes is currently associated with Glycomine, Inc., where she continues to develop her groundbreaking work in carbohydrate therapies. Her research has the potential to transform treatment options for patients suffering from metabolic disorders.
Collaborations
Agnes collaborates with Tatyana Chernenko, who is also a key figure in her research endeavors. Together, they work towards advancing the understanding and application of carbohydrate therapies in medicine.
Conclusion
Agnes Rafalko's innovative contributions to pharmaceutical carbohydrate therapies highlight her dedication to improving treatment options for metabolic disorders. Her work continues to pave the way for future advancements in this critical area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile